Federal Agency · Dept. of the Army -- USAMRAA
DoW Multiple Sclerosis Clinical Trial Award
Posted May 5, 2026
Funding
Funding amount not specified
Closes
August 13, 2026
NAICS
541715
Summary: The fiscal year 2026 (FY26) Multiple Sclerosis Research Program (MSRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of multiple sclerosis. All applications must address at least one of the FY26 MSRP CTA focus areas. Clinical trials may evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance and/or emerging approaches and technologies.
Award details
Applications close on August 13, 2026 (71 days remaining).
Categories
Not categorized
Sign up at GrantRegister to see if this grant matches your organization.
Match my organization →View application on Grants.gov →·Source: Grants.gov·Last seen Jun 2, 2026